Get Acute Email Id Full Version 245
Alke Stilwell
INTERACT (Interventions to Reduce Acute Care Transfers) is a quality improvement program that focuses on the management of acute change in resident condition. It includes clinical and educational tools and strategies for use in every day practice in long-term care facilities.
By submitting this form, you are granting: Pathway Health Services, Inc., 11240 Stillwater Blvd. N., Lake Elmo, Minnesota, 55042, United States, permission to email you. You may unsubscribe via the link found at the bottom of every email. (See our Email Privacy Policy for details.) Emails are serviced by Constant Contact.
A fix was deployed on Thursday 30th May to address the stability issues experienced with the Right Decision Service over recent weeks. These arose principally when multiple toolkits were built simultaneously or successively to the mobile app We are hopeful that the stability issues are now resolved. If you encounter any problems with this newly deployed site, please email ann.w...@nhs.scot and oniv...@tactuum.com immediately as well as raising an Urgent support ticket.
The timeline for this work has been slightly delayed because effort has been diverted to addressing the recent stability issues. However, the redesign of search, browse, archiving and version control have now been through a second round of testing and Tactuum is beginning to work on amendments. We now plan to go out to user acceptance testing in July 2024 and will let you know when we are ready to do this.
Thanks to Fergus Donachie in NHS Dumfries and Galloway and Sheila Grecian in NHS Lothian, who have shared the results of user surveys for their referral management and diabetes & endocrinology toolkits. The results provide excellent insights into how RDS is improving practice and saving time for clinicians. And there are also helpful suggestions for improving the service.
This all provides valuable material to support the business case to Scottish Government for the next stages of RDS development. If you have carried out local evaluation we would be very pleased to hear from you.
Thank you to everyone who has completed the retrospective Quality Assurance checklist. I am pleased to say that the latest report was well-received within Healthcare Improvement Scotland, with positive comments on the commitment shown by NHS Boards and other organisations to ensuring the quality and safety of their content on the RDS.
If you have any questions about the content of this newsletter, please contact his.decis...@nhs.scot If you would prefer not to receive future newsletters, please email Olivia...@nhs.scot and ask to be removed from the circulation list.
This Evidence-based Clinical Care course will review the new systemwide, pre-anesthesia/sedation testing guidelines developed for planned procedures. Adequate preoperative patient evaluation and preparation may improve patient outcomes, decrease complications and reduce incidence of acute kidney injury, delays, cancellations, costs, length of hospital stay and mortality.
Note to Physicians: Be sure to bookmark this course to access all protocols, pathways, policies and procedures at your convenience via your CME Portal account. All power plans are available in Cerner. All EBCC deliverables will be available on the EBCC website.
PHYSICIAN LEADERS
Edward Abraham, M.D., Guillermo Pol, M.D., Jose Davila, M.D., and Samir Kulkarni, M.D., have no relevant financial relationships with ineligible companies* to disclose and have indicated that the presentation or discussion will not include off-label or unapproved product usage.
Bianca Capella, APRN-BC, R.N.-BSN, and Erika Gonzalez, MSN, R.N., CCRN, NE-BC, have no relevant financial relationships with ineligible companies* to disclose and have indicated that the presentation or discussion will not include off-label or unapproved product usage.
Physician subcommittee leaders, non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose with ineligible companies*.
This site uses a responsive design, which allows the page layout of elements to change depending on the screen resolution. Certain functionality may change based on the resolution of smaller screens, such as the number of columns in a table.
Technical Support: If you are experiencing technical difficulties or have received an error message, please send an email to C...@BaptistHealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours.
Thank you very much for submitting your manuscript "Acute Chagas disease in Brazil from 2001 to 2017: A nationwide spatiotemporal analysis" for consideration at PLOS Neglected Tropical Diseases. As with all papers reviewed by the journal, your manuscript was reviewed by members of the editorial board and by several independent reviewers. In light of the reviews (below this email), we would like to invite the resubmission of a significantly-revised version that takes into account the reviewers' comments.
We cannot make any decision about publication until we have seen the revised manuscript and your response to the reviewers' comments. Your revised manuscript is also likely to be sent to reviewers for further evaluation.
[1] A letter containing a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript. Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.
Please prepare and submit your revised manuscript within 60 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email. Please note that revised manuscripts received after the 60-day due date may require evaluation and peer review similar to newly submitted manuscripts.
Thank you again for your submission. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.
Reviewer #1: The objectives are clear and in accordance with the retrospective study design. I think the sample size is sufficient is suitable to the tested hypothesis and statistical analysis supports the conclusions. Regarding ethical principles, there are no concerns.
Reviewer #1: The conclusions are appropriate to the data emphasizing the study limitations due to the quality of the analyzed data and the underreporting of Trypanosoma cruzi in the acute phase. Data analysis is well discussed considering epidemiological indicators related to the acute phase of Chagas disease. It also addresses the importance of reporting suspected cases in primary care and public health services, early diagnosis as well as the gaps regarding the availability of the etiological treatment as relevant factors in controlling the transmission of the parasite.
Use this section to provide overall comments, discuss strengths/weaknesses of the study, novelty, significance, general execution and scholarship. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. If requesting major revision, please articulate the new experiments that are needed.
Reviewer #1: This study adresses epidemiological data related to acute Chagas disease that are publicly available, analyzed the spatiotemporal distribution of notified cases of acute Chagas disease and evaluated relevant epidemiological indicators throughout Brazil from 2001 to 2017. Even with a huge difference between the number of confirmed cases of acute Chagas disease and the notification (suspected) cases reported, there was a clear increase in numbers of acute Chagas disease cases during the last decade. The importance of diagnosis and prompt treatment of cases and prolonged follow-up of patients should be strengthened in the increased risk of outbreaks, providing visibility and development of methodologies and well-designed clinical follow-up.
Reviewer #2: This is a sound analysis of acute cases of Chagas Disease during a period of 17 years. Brazil's macro regions were defined as units of analysis. Methods and conclusions are adequate. There are only some comments:
I am missing a general description of all notified cases and request to include a table with all cases diagnosed, according to available variables available such as sex, age, region, transmission route, year/period etc. (Figure 3 only gives a broad information by region/bar charts).
Acute Chagas Disease often occurs in outbreaks, especially in the case of oral transmission. In addition, a major outbreak may distort geographical analysis. I suggest to include information on major outbreaks that occurred during the study period, in the discussion section of the manuscript, and to discuss the implications adequately.
While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at fig...@plos.org.
Please note that, as a condition of publication, PLOS' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example see here:
b1e95dc632